Tags

Type your tag names separated by a space and hit enter

Sensor-augmented pump therapy in type 1 diabetes.
Curr Opin Endocrinol Diabetes Obes. 2008 Apr; 15(2):118-22.CO

Abstract

PURPOSE OF REVIEW

Recent developments in technology have ushered in a new era of managing type 1 diabetes. Continuous glucose monitoring is rapidly becoming an accepted adjunct to traditional self-monitoring of plasma glucose, and the marriage of continuous glucose sensors to continuous subcutaneous insulin infusion is the first step towards the development of a true artificial pancreas. The purpose of this review is to familiarize the reader with the new glucose sensors and discuss the literature evaluating their accuracy and effectiveness.

RECENT FINDINGS

Current models of continuous glucose sensors are still less accurate than traditional methods of blood glucose monitoring but provide information regarding trends that cannot be obtained with blood testing. Short-term studies of continuous glucose sensors have demonstrated reduction in glycosylated hemoglobin levels and time spent in hypo- and hyperglycemic ranges. Patient acceptance and satisfaction with sensors has been shown to depend on the quality of the data, comfort of wear, and ease of use.

SUMMARY

Sensor-augmented pump therapy represents a landmark improvement in diabetes treatment and will likely become the standard of care. Future work should focus on improvements in sensor accuracy and development of user-friendly algorithms to assist patients with self-management.

Authors+Show Affiliations

Department of Pediatrics, Center for Clinical Investigation, Yale University School of Medicine, New Haven, Connecticut 06520-8064, USA. stuart.weinzimer@yale.eduNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

18316945

Citation

Weinzimer, Stuart A., and William V. Tamborlane. "Sensor-augmented Pump Therapy in Type 1 Diabetes." Current Opinion in Endocrinology, Diabetes, and Obesity, vol. 15, no. 2, 2008, pp. 118-22.
Weinzimer SA, Tamborlane WV. Sensor-augmented pump therapy in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15(2):118-22.
Weinzimer, S. A., & Tamborlane, W. V. (2008). Sensor-augmented pump therapy in type 1 diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity, 15(2), 118-22. https://doi.org/10.1097/MED.0b013e3282f7960b
Weinzimer SA, Tamborlane WV. Sensor-augmented Pump Therapy in Type 1 Diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15(2):118-22. PubMed PMID: 18316945.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sensor-augmented pump therapy in type 1 diabetes. AU - Weinzimer,Stuart A, AU - Tamborlane,William V, PY - 2008/3/5/pubmed PY - 2008/4/26/medline PY - 2008/3/5/entrez SP - 118 EP - 22 JF - Current opinion in endocrinology, diabetes, and obesity JO - Curr Opin Endocrinol Diabetes Obes VL - 15 IS - 2 N2 - PURPOSE OF REVIEW: Recent developments in technology have ushered in a new era of managing type 1 diabetes. Continuous glucose monitoring is rapidly becoming an accepted adjunct to traditional self-monitoring of plasma glucose, and the marriage of continuous glucose sensors to continuous subcutaneous insulin infusion is the first step towards the development of a true artificial pancreas. The purpose of this review is to familiarize the reader with the new glucose sensors and discuss the literature evaluating their accuracy and effectiveness. RECENT FINDINGS: Current models of continuous glucose sensors are still less accurate than traditional methods of blood glucose monitoring but provide information regarding trends that cannot be obtained with blood testing. Short-term studies of continuous glucose sensors have demonstrated reduction in glycosylated hemoglobin levels and time spent in hypo- and hyperglycemic ranges. Patient acceptance and satisfaction with sensors has been shown to depend on the quality of the data, comfort of wear, and ease of use. SUMMARY: Sensor-augmented pump therapy represents a landmark improvement in diabetes treatment and will likely become the standard of care. Future work should focus on improvements in sensor accuracy and development of user-friendly algorithms to assist patients with self-management. SN - 1752-2978 UR - https://www.unboundmedicine.com/medline/citation/18316945/Sensor_augmented_pump_therapy_in_type_1_diabetes_ L2 - https://doi.org/10.1097/MED.0b013e3282f7960b DB - PRIME DP - Unbound Medicine ER -